Mineralocorticoid-induced hypertension in patients with orthostatic hypotension
about
Preventing and treating orthostatic hypotension: As easy as A, B, CPseudohyperaldosteronism: pathogenetic mechanismsExtreme metabolic alkalosis with fludrocortisone therapyMidodrine for TCA-induced orthostatic hypotensionFludrocortisone in the treatment of hypotensive disorders in the elderlyMidodrine in neurally mediated syncope: a double-blind, randomized, crossover study.Orthostatic hypotension associated with baroreceptor dysfunction: treatment approaches.Is ambulatory blood pressure monitoring useful in patients with chronic autonomic failure?New developments in the management of neurogenic orthostatic hypotension.Current pharmacological management of hypotensive syndromes in the elderly.Diagnosing and treating neurogenic orthostatic hypotension in primary care.Droxidopa in neurogenic orthostatic hypotension.Clinical Relevance of Orthostatic Hypotension in Neurodegenerative Disease.Benefits of fludrocortisone in the treatment of symptomatic vasodepressor carotid sinus syndrome.Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure.Therapeutic advances in multiple system atrophy and progressive supranuclear palsy.Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension.Pindolol acts as beta-adrenoceptor agonist in orthostatic hypotension: therapeutic implications.Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndromeCurrent pharmacologic treatment for orthostatic hypotension.Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management.Pharmacological options in the management of orthostatic hypotension in older adults.Management of neurogenic orthostatic hypotension in patients with autonomic failure.Management of orthostatic hypotension in patients with Parkinson's disease.Cardiovascular complications in patients with autonomic failure.Efficacy of Servo-Controlled Splanchnic Venous Compression in the Treatment of Orthostatic Hypotension: A Randomized Comparison With Midodrine.Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension.Sudden Unexpected Death During Sleep in Familial Dysautonomia: A Case-Control Study.Pathophysiology and Treatment of Orthostatic Hypotension in Parkinsonian Disorders.Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension.Adrenocortical factors in hypertension.ACTH dependent hypertension.Drug-induced causes of secondary hypertension.Biological and hemodynamic effects of low doses of fludrocortisone and hydrocortisone, alone or in combination, in healthy volunteers with hypoaldosteronism.Fludrocortisone Is Associated With a Higher Risk of All-Cause Hospitalizations Compared With Midodrine in Patients With Orthostatic Hypotension.Pharmacotherapy of Cardiovascular Autonomic Dysfunction in Parkinson Disease.Clinical characteristics of supine hypertension in de novo Parkinson disease.Pure Autonomic Failure.Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.Evidence for the presence in arterial walls of intracellular-molecular mechanism for action of mineralocorticoids.
P2860
Q24632844-4EFEAA6E-973F-4B36-ADE0-5FF684625799Q28191206-6AC85F85-DCF4-4B02-8E20-683C5DD7C088Q28366941-C1B66FE5-3F32-44A9-BC10-561088FBDB67Q28367508-0191E7A3-287C-4054-8519-57DDB5AD500CQ28379442-51065B36-8C3C-456D-AC97-A234F1DF5C0BQ33148062-93CC5B27-CEDE-491C-A163-AB06BBF043A9Q33163907-8B8B82D8-3554-42F4-B0D1-4D1665F9B061Q33164089-A4B40BCC-42A5-4F8B-97B4-47B39C27879CQ33164844-54755F24-69B7-4B3E-8A79-E0D9A4A6CA2FQ33165704-498ABB0A-25FE-4676-9245-C6DC0206BEBAQ33165773-9B68C517-8B5A-4335-A6BA-E18631FF0D3BQ33165878-2DFE0EE3-93F5-414F-8D3E-4443C2EF0551Q33166368-8E71077B-ABF5-412E-8146-C2F4AC98F68CQ33174515-08C7B5E2-D443-4E04-946A-6AE492C5DDF9Q34222222-1AE5A90A-A581-4728-88E5-48B6D8A5ED32Q34487619-5648AA4A-8E34-4C58-8ACC-782E2FFCDB32Q34536445-5279B7FA-D60F-43B6-838A-11C517192AA6Q34778316-20B8AFC6-224A-48C0-9670-655F37D50E15Q36164911-9749141B-29B0-4E8C-AB48-BA11EE1D2F89Q37119748-FA9206D6-3BA0-4D0D-B599-7FC7B1AB667DQ37150169-09DA4097-5EC0-4753-9BB9-DEDB452A11E9Q37629841-5AE7E1B7-A5F8-4FBC-8240-328A5F65AA9CQ38121827-99CD0CCE-0BDA-41FD-AA65-55B0401E4ACDQ38285642-AEA83557-6737-43BA-BA0B-9456A7EA5609Q38384306-3BB3EDE8-EE53-4DAB-8D0F-A3C43E64E11AQ38391626-8E8A81DB-1553-41E2-9B06-364DAA4D2BA0Q38658416-B4710C55-4D46-4134-AF91-0C72BFF1AC20Q38776926-7C61E260-8803-4A92-987A-C7078BC48A26Q38823627-E98AE569-F0B1-4CDA-93EA-F15B0F7B1081Q39438327-73E913B8-9CE8-43F5-B6A8-F25798792CD2Q39827672-9270DD20-F713-47CD-894F-D29B48AAEC25Q40142124-1E514E5B-452A-42B6-AA5B-EA41333D8114Q42359036-821CB070-F40B-46F0-B5E9-16A61C780075Q42969992-B5FB94DF-4319-40E0-B675-AE7E591FFEFDQ47162889-DE586302-2962-42AF-B1AB-04CDB693334AQ48117806-79578B1B-9CF8-4900-9D96-8B62EEE9265FQ50552849-90C3B0A6-5B23-4E16-9DBE-0D4D46467B38Q51685133-BFB4FB33-0C8C-4888-A2F7-AA89BB9FD4A3Q52672547-31983952-A5A3-4BF4-8AA6-C1C83C1B4D9DQ54523175-FB3A5C18-D760-4A3C-BB35-A780982C20E6
P2860
Mineralocorticoid-induced hypertension in patients with orthostatic hypotension
description
1979 nî lūn-bûn
@nan
1979 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
Mineralocorticoid-induced hypertension in patients with orthostatic hypotension
@ast
Mineralocorticoid-induced hypertension in patients with orthostatic hypotension
@en
Mineralocorticoid-induced hypertension in patients with orthostatic hypotension
@nl
type
label
Mineralocorticoid-induced hypertension in patients with orthostatic hypotension
@ast
Mineralocorticoid-induced hypertension in patients with orthostatic hypotension
@en
Mineralocorticoid-induced hypertension in patients with orthostatic hypotension
@nl
prefLabel
Mineralocorticoid-induced hypertension in patients with orthostatic hypotension
@ast
Mineralocorticoid-induced hypertension in patients with orthostatic hypotension
@en
Mineralocorticoid-induced hypertension in patients with orthostatic hypotension
@nl
P2093
P921
P1476
Mineralocorticoid-induced hypertension in patients with orthostatic hypotension
@en
P2093
P356
10.1056/NEJM197907123010202
P407
P577
1979-07-12T00:00:00Z